Press "Enter" to skip to content

Isofol Receives Clinical Use Patent Approval in the United States for Drug Candidate arfolitixorin – BioSpace

admin 0

Isofol Receives Clinical Use Patent Approval in the United States for Drug Candidate arfolitixorin  BioSpace

GOTHENBURG, Sweden, June 25, 2019 /PRNewswire/ — Isofol Medical AB(publ), (Nasdaq First North Premier: ISOFOL), today announced approval of a …

“liver cancer” – Google News

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *